Compare GE Vernova Inc (GEV) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE Vernova Inc vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? GE Vernova Inc trades at $1,003.76 (market cap $266.16B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.88 (market cap $25.27B). The key difference: GE Vernova Inc is far larger — about 10.5× Royalty Pharma plc Class A Ordinary Shares's market cap, and Royalty Pharma plc Class A Ordinary Shares pays the higher dividend (1.66%). Which is the better fit depends on your goals — on Pluang, investors hold GE Vernova Inc for 36 Days and Royalty Pharma plc Class A Ordinary Shares for 1 Days on average.
| GEV | RPRX | |
|---|---|---|
Market Cap | $266.16B | $25.27B |
Volume | 2,324,165 | 3,671,183 |
Sector | Industrials | Health |
52-Week High | $1.17K | $63.96 |
52-Week Low | $547.96 | $35.44 |
Typical Hold Time | 36 Days | 1 Days |
Enterprise Value | $255.83B | $32.50B |
Dividend Yield | 0.2% | 1.66% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE Vernova (GEV) trades at $1,004.73, up 0.77% with strong bullish technical momentum. The stock shows exceptional profitability with 23.04% net margins and 91.48% ROE, though valuation appears elevated with P/E of 28.65. Recent Q2 2026 earnings missed expectations, but Q1 and Q4 2025 results significantly beat forecasts. The company secured the first US construction permit for its BWRX-300 SMR, strengthening its nuclear pipeline amid growing AI-driven power demand.
Outlook remains positive with 75.86% analyst buy ratings and $1,270 consensus price target representing 26% upside. Key risks include execution challenges in wind segment and valuation concerns. Strong backlog growth to $176 billion and AI power demand create substantial growth runway, though investors should monitor margin expansion and competitive pressures.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE Vernova Inc
GE Vernova is a global leader in the electric power industry. It provides sustainable energy solutions across gas, wind, and hydro sectors, focusing on modernizing the world's power grids.
Read more on GEV →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
